ULTRACEMCO - UltraTech Cement Limited
NSE
->
Basic Materials
->
Building Materials
Mumbai,
India
Type: Equity
ULTRACEMCO price evolution
ULTRACEMCO
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7610.9 | $3591.8 | ||
| Short term investments | $21496 | $49633.4 | ||
| Net receivables | $40476.7 | $30785.6 | ||
| Inventory | $69304.8 | $55955.8 | ||
| Total current assets | $181839.7 | $174894.7 | ||
| Long term investments | $14673.1 | $13724.3 | ||
| Property, plant & equipment | $502011.7 | $485480.4 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $862332.2 | $838277.9 | ||
| Current liabilities | ||||
| Accounts payable | $55374.8 | $58628.3 | ||
| Deferred revenue | ||||
| Short long term debt | $48998.4 | |||
| Total current liabilities | $200545.5 | $201551.9 | ||
| Long term debt | $64854.3 | $53030 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $347489.6 | $333955.8 | ||
| Shareholders' equity | ||||
| Retained earnings | $443784.6 | |||
| Other shareholder equity | $511971.8 | $501466 | ||
| Total shareholder equity | $514858.5 | $504352.7 | $504352.7 | $461628.6 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3591.8 | $20075.5 | $1465.3 | $4412.4 |
| Short term investments | $49633.4 | $127935.2 | $3608.8 | $1768.5 |
| Net receivables | $30785.6 | $26864.8 | $34982.3 | $38924.6 |
| Inventory | $55955.8 | $40179.7 | $41483.1 | $40989.6 |
| Total current assets | $174894.7 | $240502.9 | $150073.7 | $129542.4 |
| Long term investments | $13724.3 | $18388.2 | $17301.6 | $14072.6 |
| Property, plant & equipment | $485480.4 | $453063.1 | $460223.5 | $457919.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $838277.9 | $861835.1 | $793371.3 | $765374.3 |
| Current liabilities | ||||
| Accounts payable | $58628.3 | $46992.8 | $35014.3 | $31597 |
| Deferred revenue | ||||
| Short long term debt | $48998.4 | $27041.9 | $15453.2 | $10182.2 |
| Total current liabilities | $201551.9 | $205917.2 | $166307.5 | $155332.5 |
| Long term debt | $53030 | $135484.5 | $173675.2 | $206503.8 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $333955.8 | $420031.1 | $402141.3 | $427746.3 |
| Shareholders' equity | ||||
| Retained earnings | $443784.6 | $378982.9 | $328313.4 | $273222.1 |
| Other shareholder equity | $501466 | $438860.3 | $6211.5 | $61570.4 |
| Total shareholder equity | $504352.7 | $441746.8 | $391154.8 | $337506.5 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $138926.9 | $151639.8 | $157672.8 | $130554.3 |
| Cost of revenue | $63137.9 | $62957 | $66924 | $52819.8 |
| Gross Profit | $75789 | $88682.8 | $90748.8 | $77734.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $37349.1 | $39277.1 | $41062.6 | $35477.3 |
| Total operating expenses | $127339.6 | $127643 | $133978.9 | $112397.4 |
| Operating income | $11587.3 | $23996.8 | $23693.9 | $18156.9 |
| Income from continuing operations | ||||
| EBIT | $11587.3 | $23996.8 | $23693.9 | $18156.9 |
| Income tax expense | $3444.9 | $7114 | -$1979.9 | -$760 |
| Interest expense | -$2003.1 | -$2157.6 | -$2063.1 | -$1823.1 |
| Net income | ||||
| Net income | $7557.3 | $15840.8 | $26204.3 | $17077.2 |
| Income (for common shares) | $7557.3 | $15840.8 | $26204.3 | $17077.2 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $525988.3 | $447258 | $421248.3 | $416088.1 |
| Cost of revenue | $201022.5 | $154169.9 | $156665.8 | $172048.7 |
| Gross Profit | $324965.8 | $293088.1 | $264582.5 | $244039.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $142470.1 | $123963.4 | $123790.7 | $127942.8 |
| Total operating expenses | $437992.3 | $358581.2 | $355168.3 | $366806.1 |
| Operating income | $87996 | $88676.8 | $66080 | $49282 |
| Income from continuing operations | ||||
| EBIT | $87996 | $88676.8 | $66080 | $49282 |
| Income tax expense | $11900.6 | $25387 | -$5681.6 | $10680.7 |
| Interest expense | -$9447.1 | -$14856.5 | -$19117.9 | -$17632.7 |
| Net income | ||||
| Net income | $73443.1 | $54631 | $58148.4 | $24035.1 |
| Income (for common shares) | $73443.1 | $54631 | $58148.4 | $24035.1 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $7557.3 | $15840.8 | $26204.3 | $17077.2 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $73443.1 | $54631 | $58148.4 | $24035.1 |
| Operating activities | ||||
| Depreciation | $27147.5 | $27002.3 | $26520.5 | $24029.4 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $92832.4 | $125029.5 | $89020.2 | $59561.1 |
| Investing activities | ||||
| Capital expenditures | -$56134.1 | -$19248.7 | -$17062 | -$17561.8 |
| Investments | $76887.9 | -$70949.4 | -$27833.3 | $26613.9 |
| Total cash flows from investing | $22570.1 | -$88590 | -$42093.5 | $11138.2 |
| Financing activities | ||||
| Dividends paid | -$10650 | -$3748 | -$3150.6 | -$3461.6 |
| Sale and purchase of stock | ||||
| Net borrowings | -$103285.9 | -$25149.1 | -$26662.7 | -$46481.8 |
| Total cash flows from financing | -$124979.3 | -$43564.7 | -$49911.3 | -$67572.4 |
| Effect of exchange rate | -$4.7 | $3.3 | $37.5 | $4.5 |
| Change in cash and equivalents | -$566.7 | $299.8 | -$2947.1 | $3640.5 |
News
|
Top 20 Most Valuable Indian Companies
Insider Monkey via Yahoo Finance
20 Nov 2023
|
|
Shradha Binani granted time to file rejoinder to SFIO affidavit, says Bombay High Court
MSN News
12 Jan 2022
|
|
UltraTech Q2 Results Preview – Experts see topline growing 11% to Rs 11,300 crore
MSN News
18 Oct 2021
|
|
Ultratech Cement Q2FY22 Earnings Results – Net sales up 14.4% YoY at 11,743 cr below estimates; PAT...
MSN News
18 Oct 2021
|
|
UltraTech Cement Q2 Result | Consolidated profit rises 13% YoY to Rs 1,314 crore, revenue grows to...
MSN News
18 Oct 2021
|
|
UltraTech Cement (NSE:ULTRACEMCO) Has A Pretty Healthy Balance Sheet
Simply Wall St. via Yahoo Finance
22 Sep 2019
|
|
Investors Who Bought UltraTech Cement (NSE:ULTRACEMCO) Shares Five Years Ago Are Now Up 72%
Simply Wall St. via Yahoo Finance
22 Sep 2019
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $578.79B |
|---|---|
| EBITDA | N/A |
| EBIT | $77.43B |
| Net Income | $66.68B |
| Revenue Q/Q | 15.61% |
| Revenue Y/Y | 14.60% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | 13.44% |
| Debt/Equity | 0.66 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.91 |
| Quick ratio | 0.56 |